Hear From The Experts

Got Questions, We've Got the Answers!

Biocombination No.22 is the combination of biochemic medicines which is indicated in suppurating scrofulous abscesses, and is composed of Calcarea phosphorica, Ferrum phosphoricum, Kali muriaticum and Silicea in equal proportion.

Biocombination No.22 is found useful in dry and suppurating scrofulous abscesses. The term scrofulous means it is a morbid state characterized by indolent glandular tumors that suppurate slowly, heal with difficulty and leave scars. Calcarea phosphorica is indicated in scrofulosis, chlorosis, and phthisis covering tubercular glandular enlargements. Ferrum phosphoricum is used in acute exacerbation of tuberculosis, inflamed throat, ulcerated sore throat, and restlessness with fever. Kali muriaticum is indicated in the enlargement of tonsils, lymph glands, sore throat, follicular tonsillitis, vesicles, and bursitis. Silicea is indicated in scrofulous children and controls abscesses, organic changes, and suppurative processes.

No side effects have been reported so far when taken as directed.

It should be taken as long as symptoms persist or as advised by the physician.

No specific contraindications have been reported. However, it is advisable for children, pregnant, or breastfeeding women to consult a physician before use.

No special precautions are generally required. It is recommended to follow the prescribed dosage and consult a physician if you have any concerns.